Are you Dr. Cha?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
Box 1270 - M1286
San Francisco, CA 94143Phone+1 415-885-7276Fax+1 415-476-0624- Is this information wrong?
Summary
- Dr. Edward Cha, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California and New York. He is a Clinical Fellow at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2008 - 2010
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2005 - 2008
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2005
Certifications & Licensure
- CA State Medical License 2008 - 2025
- NY State Medical License 2007 - 2009
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma Start of enrollment: 2012 Jun 09
Publications & Presentations
PubMed
- 3 citationsPhase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors.Christian U Blank, Deborah J Wong, Thai H Ho, Todd M Bauer, Carrie B Lee, Fabiola Bene-Tchaleu, Jing Zhu, Xiaosong Zhang, Edward Cha, Mario Sznol> ;Current Oncology. 2021 Dec 20
- 18 citationsEpigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.Raghav Sundar, Kie-Kyon Huang, Vikrant Kumar, Kalpana Ramnarayanan, Deniz Demircioğlu, Zhisheng Her, Xuewen Ong, Zul Fazreen Adam Isa, Manjie Xing, Angie Lay-Keng Tan,...> ;Gut. 2021 Aug 25
- 6 citationsSafety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Results From a Phase 1b Trial.Deborah J. Wong, Todd M. Bauer, Michael S. Gordon, Fabiola Bene-Tchaleu, Jing Zhu, Xiaosong Zhang, Edward Cha> ;Clinical Lung Cancer. 2021 Jul 20
- Join now to see all